Tag #Mifepristone

Showing 1 to 12 of 16 results

theguardian.com

🌐 85% Global Worthiness

Sep 5, 01:19

Kennedy Claims Biden Admin "Twisted Data" on Abortion Pills, Threatens Rollback

US Health Secretary Robert F Kennedy Jr. accused the Biden administration of manipulating data on abortion pills, suggesting potential rollbacks of expanded access regulations, a claim disputed by over 100 studies confirming the pills' safety and efficacy.

Kennedy Claims Biden Admin "Twisted Data" on Abortion Pills, Threatens Rollback

US Health Secretary Robert F Kennedy Jr. accused the Biden administration of manipulating data on abortion pills, suggesting potential rollbacks of expanded access regulations, a claim disputed by over 100 studies confirming the pills' safety and efficacy.

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What specific claims did Kennedy make regarding the safety and regulation of abortion pills, and what evidence, if any, did he provide?

Kennedy alleged the Biden administration "twisted data" to hide a significant safety signal related to abortion pills, citing an 11% complication rate. He offered no supporting evidence beyond a flawed, non-peer-reviewed analysis from a right-wing think tank, which mischaracterizes ectopic pregnancies as a complication caused by mifepristone.

elmundo.es

🌐 75% Global Worthiness

Aug 15, 04:14

Mifepristone Shows Promise in Breast Cancer Prevention Despite Barriers

Research suggests mifepristone, a drug used in medical abortions, may prevent breast cancer by blocking progesterone's effects on breast cells; however, ethical concerns, high costs, and limited large-scale trials hinder its wider application.

Mifepristone Shows Promise in Breast Cancer Prevention Despite Barriers

Research suggests mifepristone, a drug used in medical abortions, may prevent breast cancer by blocking progesterone's effects on breast cells; however, ethical concerns, high costs, and limited large-scale trials hinder its wider application.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the potential of mifepristone in preventing breast cancer, considering the existing evidence and obstacles?

Breast cancer remains the leading cause of cancer death in women. While detection and treatment efforts are ongoing, a new focus is on prevention. Research suggests that mifepristone, known for medical abortion, may reduce breast cancer risk by blocking progesterone's action on breast tissue cells, potentially mitigating growth and changes linked to cancer development.

themoscowtimes.com

🌐 85% Global Worthiness

Jul 2, 22:14

Russia's Mifepristone Restrictions Cause Nationwide Contraceptive Shortage

Russia's September 2024 reclassification of mifepristone as a controlled substance has led to a nationwide shortage of emergency contraceptives and medical abortion drugs, impacting women's reproductive healthcare access amid a demographic crisis and record-low birth rates.

Russia's Mifepristone Restrictions Cause Nationwide Contraceptive Shortage

Russia's September 2024 reclassification of mifepristone as a controlled substance has led to a nationwide shortage of emergency contraceptives and medical abortion drugs, impacting women's reproductive healthcare access amid a demographic crisis and record-low birth rates.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of Russia's tighter controls on mifepristone regarding access to emergency contraception and medical abortion?

Russia's new restrictions on mifepristone, effective September 2024, have severely limited access to emergency contraceptives and medical abortion drugs. Two common emergency contraceptives, Jenale and Ginepriston, are unavailable in pharmacies nationwide. This follows a one-third decrease in mifepristone and misoprostol shipments to hospitals in 2024, reaching the lowest recorded consumption levels.

forbes.com

🌐 85% Global Worthiness

May 6, 01:16

Trump FDA Dismisses Lawsuit Challenging Abortion Drug Mifepristone

The Trump administration's FDA moved to dismiss a lawsuit from conservative states aiming to limit access to the abortion drug mifepristone, echoing the Biden administration's position; medication abortions now comprise 63% of all abortions in the U.S.

Trump FDA Dismisses Lawsuit Challenging Abortion Drug Mifepristone

The Trump administration's FDA moved to dismiss a lawsuit from conservative states aiming to limit access to the abortion drug mifepristone, echoing the Biden administration's position; medication abortions now comprise 63% of all abortions in the U.S.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the Trump administration's FDA decision on mifepristone access?

The Trump administration's FDA filed to dismiss a lawsuit challenging mifepristone access, aligning with the Biden administration's position. This decision maintains the drug's availability, despite challenges from conservative states seeking to restrict abortion access. Medication abortions now account for 63% of all abortions in the U.S., up from 53% in 2020.

theguardian.com

🌐 85% Global Worthiness

May 6, 04:09

Trump Administration Defends Mifepristone Access Amidst Legal Challenge

The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.

Trump Administration Defends Mifepristone Access Amidst Legal Challenge

The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.

Progress

32% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What is the immediate impact of the Trump administration's decision to defend the FDA's mifepristone regulations?

The Trump administration is defending FDA regulations that eased access to the abortion drug mifepristone, rejecting a lawsuit from three Republican-led states. The lawsuit challenges FDA actions allowing telemedicine prescriptions and mail delivery of the drug, claiming improper procedure. The Justice Department seeks dismissal on procedural grounds, arguing the states lack standing to sue.

theguardian.com

🌐 90% Global Worthiness

Feb 1, 19:07

ADF Intensifies Efforts to Restrict Abortion Access in the US

The Alliance Defending Freedom (ADF), a conservative legal group, is employing various legal strategies to restrict abortion access in the US, including lawsuits targeting medication abortion and efforts to defund Planned Parenthood, following the overturning of Roe v. Wade.

ADF Intensifies Efforts to Restrict Abortion Access in the US

The Alliance Defending Freedom (ADF), a conservative legal group, is employing various legal strategies to restrict abortion access in the US, including lawsuits targeting medication abortion and efforts to defund Planned Parenthood, following the overturning of Roe v. Wade.

Progress

64% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What are the potential long-term implications of the ADF's legal challenges on abortion access, considering potential Supreme Court rulings and the role of the executive branch?

The ADF's actions are likely to lead to increased polarization and legal challenges surrounding abortion access. The potential for future constitutional crises highlights the far-reaching implications of their legal strategies. Continued litigation and executive actions under the Trump administration may further restrict abortion rights.

abcnews.go.com

🌐 85% Global Worthiness

Aug 23, 07:17

Lawsuit Challenges FDA Mifepristone Restrictions

In Honolulu, a lawsuit challenges FDA restrictions on the abortion drug mifepristone, arguing that they're unscientific and hinder access for those in low-income or rural areas; the judge will decide if these restrictions violate the law.

Lawsuit Challenges FDA Mifepristone Restrictions

In Honolulu, a lawsuit challenges FDA restrictions on the abortion drug mifepristone, arguing that they're unscientific and hinder access for those in low-income or rural areas; the judge will decide if these restrictions violate the law.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the specific FDA restrictions on mifepristone access, and how do they directly impact patients' ability to obtain the medication?

The American Civil Liberties Union (ACLU) is challenging FDA restrictions on mifepristone, arguing they lack scientific justification and disproportionately affect patients with limited healthcare access. A Hawaii doctor and healthcare associations are plaintiffs, seeking to have the FDA correct these restrictions, which include special certification for prescribers and pharmacies, and a mandatory counseling form. This case, ongoing since 2017, highlights the ongoing political battle surrounding mifepristone access.

foxnews.com

🌐 85% Global Worthiness

Aug 13, 13:19

Republican AGs Demand Reinstatement of Mifepristone Safety Protocols

Twenty-two Republican attorneys general are demanding that the FDA reinstate safety protocols for the abortion drug mifepristone, citing studies showing serious adverse events are 22 times more frequent than stated on the label, and calling for stricter regulations or market removal if safeguards ar...

Republican AGs Demand Reinstatement of Mifepristone Safety Protocols

Twenty-two Republican attorneys general are demanding that the FDA reinstate safety protocols for the abortion drug mifepristone, citing studies showing serious adverse events are 22 times more frequent than stated on the label, and calling for stricter regulations or market removal if safeguards ar...

Progress

64% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term consequences of the FDA's decision regarding the safety protocols and market availability of mifepristone?

The ongoing debate over mifepristone's safety and accessibility underscores a broader political and ideological struggle surrounding abortion rights. This legal challenge could significantly impact abortion access in the U.S., potentially leading to stricter regulations or a complete ban on the drug depending on the FDA's response and subsequent legal action. The FDA's decision will influence the future landscape of medication abortion.

theguardian.com

🌐 85% Global Worthiness

Jun 23, 22:15

US Abortion Numbers Rise Despite State Bans

In 2024, a record 1.14 million abortions were performed in the US, despite bans in numerous states; this increase is largely due to telehealth abortions facilitated by "shield laws", while reported in-person abortions in states with total bans averaged only 30 per month.

US Abortion Numbers Rise Despite State Bans

In 2024, a record 1.14 million abortions were performed in the US, despite bans in numerous states; this increase is largely due to telehealth abortions facilitated by "shield laws", while reported in-person abortions in states with total bans averaged only 30 per month.

Progress

48% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What is the overall impact of state-level abortion bans on the total number of abortions performed in the US in 2024?

Despite a dozen states banning abortion post-Roe v Wade, the number of abortions in the US rose to a record 1.14 million in 2024. This increase is largely due to telehealth abortions, facilitated by "shield laws" protecting providers from prosecution in states with abortion bans. Telehealth abortions rose from 19% to 25% of all abortions between 2023 and 2024.

theglobeandmail.com

🌐 85% Global Worthiness

May 6, 04:09

Trump Administration Defends Mifepristone Access in Legal Challenge

The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.

Trump Administration Defends Mifepristone Access in Legal Challenge

The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.

Progress

44% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

How do the states' arguments regarding Medicaid costs relate to their standing in this lawsuit?

This legal challenge, initiated during the Biden administration and continued under Trump, highlights the ongoing political battle surrounding abortion access in the United States. The states' claim that their Medicaid programs will face increased costs due to mifepristone complications is central to their argument for standing. The case's trajectory influences abortion policy nationwide.

npr.org

🌐 85% Global Worthiness

May 6, 10:12

Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access

The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.

Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access

The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.

Progress

44% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

How do the varying abortion laws across the three states involved shape their legal arguments?

This legal challenge connects to broader debates surrounding abortion access and states' rights. The states' attempt to leverage a previous lawsuit highlights the strategic maneuvering around legal challenges to abortion-related policies. The differing stances on abortion access among states underscore the complex and politically charged nature of the issue.

cbsnews.com

🌐 85% Global Worthiness

Jan 30, 04:09

Kennedy's Abortion Pledge: Impact on Mifepristone Regulation

Robert F. Kennedy Jr. pledged at a Senate hearing to implement President Trump's abortion policies if confirmed as HHS Secretary, prompting praise from some conservative groups and alarm from Democrats who cited his past pro-choice statements. This decision significantly impacts abortion access nati...

Kennedy's Abortion Pledge: Impact on Mifepristone Regulation

Robert F. Kennedy Jr. pledged at a Senate hearing to implement President Trump's abortion policies if confirmed as HHS Secretary, prompting praise from some conservative groups and alarm from Democrats who cited his past pro-choice statements. This decision significantly impacts abortion access nati...

Progress

56% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What are the potential long-term consequences of Kennedy's confirmation on abortion access and healthcare policy in the United States?

Kennedy's confirmation could significantly alter abortion access in the US. His pledge to enforce Trump's abortion policies, including potential restrictions on mifepristone and Title X funding, signals a shift towards more restrictive regulations. Future litigation and challenges to these policies are likely.

Showing 1 to 12 of 16 results